is head of the IP Enforcement & Protection practice. She holds a master’s degree in science and an LL.M from Stanford Law School. She has a strong technical background in life sciences and has helped many pharmaceutical, biotech, and medical-device companies on intellectual property, regulatory, and commercial issues. Ms Cheng’s intellectual property practice encompasses intellectual property litigation, licensing and technology transfer, IP-related antitrust review, and client counselling on a variety of IP issues. Ms Cheng also provides consultation opinions on drug registration, market entrance, pricing, drug labelling, advertising and promotional activities, and industry-specific compliance issues. She is Adjunct professor of East China University of Politics and Law and a member of a number of professional bodies including Alternative Dispute Resolution Committee, International Association for the Protection of Intellectual Property (AIPPI ). She has contributed regularly to industry publications.